rs879253851
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PVS1_StrongPM2PP2PP5_Very_Strong
The NM_000255.4(MMUT):c.2194_2197delGCCGinsTGGAA(p.Ala732TrpfsTer6) variant causes a frameshift, missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. A732A) has been classified as Benign.
Frequency
Consequence
NM_000255.4 frameshift, missense
Scores
Clinical Significance
Conservation
Publications
- methylmalonic aciduria due to methylmalonyl-CoA mutase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
- vitamin B12-unresponsive methylmalonic acidemia type mut-Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- vitamin B12-unresponsive methylmalonic acidemia type mut0Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000255.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MMUT | NM_000255.4 | MANE Select | c.2194_2197delGCCGinsTGGAA | p.Ala732TrpfsTer6 | frameshift missense | Exon 13 of 13 | NP_000246.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MMUT | ENST00000274813.4 | TSL:1 MANE Select | c.2194_2197delGCCGinsTGGAA | p.Ala732TrpfsTer6 | frameshift missense | Exon 13 of 13 | ENSP00000274813.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change creates a premature translational stop signal (p.Ala732Trpfs*6) in the MUT gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 19 amino acid(s) of the MUT protein. For these reasons, this variant has been classified as Pathogenic. This variant is also known as 2270del4/ins5 and c.2194-2197del4ins5 (p.Ala732fsX737). This premature translational stop signal has been observed in individual(s) with methylmalonic acidemia (PMID: 10923046, 16281286, 16435223, 27167370). Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database.
MMUT: PVS1, PM2, PS4:Supporting
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency Pathogenic:2
Methylmalonic acidemia Pathogenic:1
Variant summary: MUT c.2194_2197delinsTGGAA (p.Ala732TrpfsX6) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 246164 control chromosomes (gnomAD). c.2194_2197delinsTGGAA has been reported in the literature in individuals affected with Methylmalonic Acidemia (Cavicchi_2005, Forny_2016, Worgan_2006). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal activity. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at